Le Lézard
Classified in: Health, Science and technology, Business
Subject: JVN

Thermo Fisher and Leica Collaborate to Develop Integrated Cryo-tomography Workflow Solution


WALTHAM, Mass. and WETZLAR, Germany, April 27, 2018 /PRNewswire/ -- Thermo Fisher Scientific and Leica Microsystems today announced a technology collaboration to develop an integrated and comprehensive cryo-tomography workflow for life sciences. The hardware and software solution is intended to seamlessly integrate light microscopes from Leica with cryo-electron microscopes from Thermo Fisher providing researchers and scientists faster and better insight into the mechanisms of diseases to accelerate scientific discoveries.

"By combining expertise from our respective companies, the cryo-tomography workflow should provide our customers with improved ease of use and reliability," said Rob Krueger, vice president and general manager, life sciences, Thermo Fisher. "Combining the supramolecular structure information scientists receive from light microscopy with the highly resolved perspective offered by electron microscopy creates the structural framework to gain deeper insight into biological processes."

In order to understand the complexity of molecular machines, it is important to investigate them using both light and electron microscopy. The integrated approach allows researchers to safely transfer vitrified samples from a cryo-light microscope to a cryo-electron microscope. In addition, the new cryo-tomography workflow will be designed to allow a full data transfer from the light to the electron microscope and to enable users to easily navigate to the targeted protein structure using specific coordinates in the electron microscope. This ensures comprehensive insight in the macromolecule architecture.

"Our customers have asked for an integrated and reliable solution for the correlation between light and electron microscopy data, so called CLEM approaches," said Markus Lusser, President of Leica Microsystems. "The collaboration insights about cellular dynamics given by light microscopes can be combined in a straightforward way with the structural knowledge that electron microscopes provide. This advancement will boost research and understanding of unresolved questions about cellular mechanisms that are the missing links in treating mankind´s diseases."  

More information about the comprehensive cryo-tomography workflow for Life Sciences can be found at thermofisher.com/cryo-tomography or leica-microsystems.com/cryo-tomography.

About Leica Microsystems

Leica Microsystems develops and manufactures microscopes and scientific instruments for the analysis of microstructures and nanostructures. Widely recognized for optical precision and innovative technology, the company is one of the market leaders in compound and stereo microscopy, digital microscopy, confocal laser scanning and super-resolution microscopy with related imaging systems, electron microscopy sample preparation, and surgical microscopy. For more information, please visit www.leica-microsystems.com.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands ? Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services ? we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.

Media Contact Information:

Kathy Gill
Thermo Fisher Scientific
+1 503-726-7684
[email protected]

Alexander Weis
Leica Microsystems GmbH
+49 6441 29-2550
[email protected]  

 

SOURCE Thermo Fisher Scientific


These press releases may also interest you

at 15:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 11:55
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 09:00
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

at 07:56
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 06:00
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

at 05:00
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: